Sanara Medtech Inc Revenue Growth Rates (SMTI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Sanara Medtech Inc   (NASDAQ: SMTI)
 

SMTI's Revenue Growth by Quarter and Year

Sanara Medtech Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SMTI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 28.14
1st Quarter March 26.87
FY 55.01

SMTIs Annual Revenue
Sanara Medtech Inc 's Revenue in the fiscal year 2025 $ 102.60 millions
Sanara Medtech Inc 's Revenue in the fiscal year 2024 $ 86.53 millions
Sanara Medtech Inc 's Revenue in the fiscal year 2023 $ 64.14 millions
Sanara Medtech Inc 's Revenue in the fiscal year 2022 $ 45.84 millions
Sanara Medtech Inc 's Revenue in the fiscal year 2021 $ 24.14 millions




SMTI Revenue second quarter 2026 Y/Y Growth Comment
Sanara Medtech Inc reported Revenue increase of 13.04% year on year in the second quarter 2026, to $ 28.14 millions, this is lower than Sanara Medtech Inc 's recent average Revenue surge of 157.25%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 79 other companies have achieved higher Revenue growth. While Sanara Medtech Inc ' s Revenue growth of 13.04% ranks overall at the positon no. 1442 in the second quarter 2026.


SMTI Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 5.63 % 57.82 % 16.06 %
3rd Quarter September - 23.11 % 35.43 % 17.1 %
2nd Quarter June 13.04 % 23.52 % 29.42 % 61.01 %
1st Quarter March 18.89 % 28.05 % 13.72 % 98.72 %
FY   - 18.55 % 34.92 % -

Financial Statements
Sanara Medtech Inc 's second quarter 2026 Revenue $ 28.14 millions SMTI's Income Statement
Sanara Medtech Inc 's second quarter 2025 Revenue $ 24.89 millions Quarterly SMTI's Income Statement


SMTI Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 16.42 % 35.69 % 16.44 %
3rd Quarter September - 2.29 % 2.63 % -1.93 %
2nd Quarter June 4.71 % 10.13 % 14.16 % 0.32 %
1st Quarter March -9.35 % -19.46 % -0.73 % 1.31 %
FY (Year on Year)   - 18.55 % 34.92 % -


Back to SMTI Growth rate Comparisons >> Back to SMTI Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #80
Healthcare Sector #247
Overall #1442

Revenue Y/Y Growth Statistics
High Average Low
6953.66 % 157.25 % -97.2 %
(Dec 31 2019)   (Dec 31 2018)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #80
Healthcare Sector #247
Overall #1442
Revenue Y/Y Growth Statistics
High Average Low
6953.66 % 157.25 % -97.2 %
(Dec 31 2019)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Sanara Medtech Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5131.5 % 98.2 % -96.97 %
(Mar 31 2019)  


SMTI's II. Quarter Q/Q Revenue Comment
Sanara Medtech Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.71% quarter on quarter, to $ 28.14 millions.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Sanara Medtech Inc 's Revenue growth quarter on quarter, overall rank is 1161.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #174
Overall #1161
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #174
Overall #1161
Revenue Q/Q Growth Statistics
High Average Low
5131.5 % 98.2 % -96.97 %
(Mar 31 2019)  


SMTI's II. Quarter Q/Q Revenue Comment
Sanara Medtech Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.71% quarter on quarter, to $ 28.14 millions.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Sanara Medtech Inc 's Revenue growth quarter on quarter, overall rank is 1161.


Sanara Medtech Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 110.12 $ 106.87 $ 102.60 $ 101.01 $ 96.23
Y / Y Revenue Growth (TTM) 14.43 % 16.82 % 18.56 % 32.47 % 35.83 %
Year on Year Revenue Growth Overall Ranking # 465 # 333 # 300 # 546 # 579
Seqeuential Revenue Change (TTM) 3.03 % 4.17 % 1.57 % 4.97 % 5.18 %
Seq. Revenue Growth (TTM) Overall Ranking # 2027 # 1604 # 846 # 1416 # 1308


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Sanara Medtech Inc 's cumulative twelve months Revenue were $ 110 millions, company would post below average annual Revenue growth of 5.18% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Sanara Medtech Inc 's Revenue growth from the 26.87% growth in Mar 31 2026.

In the Healthcare sector 114 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 333 to 465.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 115
Overall # 465

Revenue TTM Y/Y Growth Statistics
High Average Low
101.56 %
 42.22 %
-7.41 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2027
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Sanara Medtech Inc 's cumulative twelve months Revenue were $ 110 millions, company would post below average annual Revenue growth of -7.41% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Sanara Medtech Inc 's Revenue growth from the 26.87% growth in Mar 31 2026.

In the Healthcare sector 114 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 333 to 465.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 115
Overall # 465

Revenue TTM Y/Y Growth Statistics
High Average Low
101.56 %
42.22 %
-7.41 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2027




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SMTI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Vericel Corporation22.48%$ 22.481 millions
Milestone Scientific Inc 22.28%$ 22.276 millions
Alpha Teknova Inc 22.05%$ 22.045 millions
X4 Pharmaceuticals Inc21.64%$ 21.642 millions
Exagen Inc 21.63%$ 21.629 millions
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions
Anika Therapeutics Inc 19.18%$ 19.176 millions
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions
Camp4 Therapeutics Corporation18.84%$ 18.838 millions
Lensar Inc 18.37%$ 18.371 millions
Immunocore Holdings Plc18.34%$ 18.336 millions
Innovage Holding Corp 18.31%$ 18.307 millions
Koru Medical Systems Inc 18.15%$ 18.153 millions
Clearpoint Neuro Inc 18.07%$ 18.068 millions
Avita Medical Inc 17.83%$ 17.830 millions
Xencor Inc17.46%$ 17.458 millions
Logicmark Inc17.39%$ 17.387 millions
Ensign Group Inc17.33%$ 17.325 millions


About Sanara Medtech Inc Revenue Growth Rates (SMTI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Sanara Medtech Inc (CIK 714256).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-037176
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Sanara Medtech Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.